The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

By A. Levey, P. D. de Jong, Josef Coresh, M. El Nahas, B. Astor, K. Matsushita, R. Gansevoort, B. Kasiske, Kai-Uwe Eckardt. Kidney International, 2011

2,281 citations recorded by the source corpus.

Subfields: Nephrology

View Paper: https://www.semanticscholar.org/paper/330eb51a2cf24359f62faece1f48e0b9d520ba51

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Nephrology

1. A. Levey
2. Josef Coresh
3. B. Astor
4. Tom Greene
5. Marcello Tonelli
6. Harold I. Feldman
7. A. Levin
8. K. Matsushita

Citations in the corpus

• Comparison of risk prediction using the CKD-EPI equation and the MDRD Study equation for estimated glomerular filtration rate (2012, neutral): “Recent reports suggest using albuminuria in addition to GFR for CKD staging and risk classification.(76,77) Our findings suggest the CKDEPI equation will be more useful than the MDRD Study equation for this application.”
• KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. (2014, background): “KDIGO convened such a conference in 2009, with the goal of addressing the shortfalls of the KDOQI staging system.(6) Analyses performed for the purpose of this conference demonstrated that GFR and albuminuria are independent and complementary predictors of important clinical outcomes, including CKD ”
• Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002, background): “An eGFR of ,60 mL/min, regardless of the presence of low levels of albuminuria, is an independent cardiovascular risk factor (325,327).”
• Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011, methodology): “The report of the Consensus Conference is included in this issue of Kidney International.(10) As part of the process, the CKD Prognosis Collaboration was formed to undertake a comprehensive analysis of mortality and kidney outcomes according to estimated GFR and albuminuria, to answer key questions ”
• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017, background): “CKD is defined as abnormalities of structure or function of the kidney, present for greater than three months, with implications for health.(4,10) Despite the many recognized causes such as diabetes, hypertension, vascular disease, or glomerulonephritis (GN), the aetiology of CKD remains uncertain i”
• Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2002, background): “An eGFR of ,60 mL/min, regardless of the presence of low levels of albuminuria, is an independent cardiovascular risk factor (325,327).”
• Association of estimated glomerular filtration rate and albuminuria with mortality and end-stage renal disease: a collaborative meta-analysis of kidney disease cohorts (2011, methodology): “Study variables eGFR was calculated using the Modification of Diet in Renal Disease (MDRD) Study equation using age, sex, race, and serum creatinine concentration.(1,21) Each participating study group was asked to standardize the serum creatinine measurements to isotope dilution mass spectrometry-tr”